Bionor Immuno AS is a business that focuses on research and development of technology and vaccines. The company aims to make a difference for patients who need therapeutic or preventive vaccines. Over the years, Bionor Immuno has implemented advanced technology in its research and development to create safe vaccines that address significant medical needs.
The company works to develop vaccines that require specific strategies for the selection and design of target peptide antigens. These peptides take into account the unique characteristics of each vaccine target, as well as the genetic profile of the vaccine recipients. Bionor Immuno AS is thus engaged in meeting the challenges associated with the development of vaccines for complex medical conditions.
